Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
13,253
archived clinical trials in
Arthritis

Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Springfield Clinic - Clinical Research
mi
from
Springfield, IL
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Springfield Clinic - Clinical Research
mi
from
Springfield, IL
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Arizona Arthritis & Rheumatology Associates, PC
mi
from
Phoenix, AZ
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Arizona Arthritis & Rheumatology Associates, PC
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Allergy, Asthma, Arthritis, & Lung
mi
from
Daytona Beach, FL
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Allergy, Asthma, Arthritis, & Lung
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Louisiana State University Health Sciences Center
mi
from
New Orleans, LA
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Louisiana State University Health Sciences Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
QUEST Research Institiute
mi
from
Bingham Farms, MI
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
QUEST Research Institiute
mi
from
Bingham Farms, MI
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
West Tennessee Research Institute
mi
from
Jackson, TN
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
West Tennessee Research Institute
mi
from
Jackson, TN
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Med Investigations
mi
from
Fair Oaks, CA
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Med Investigations
mi
from
Fair Oaks, CA
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Office of Anupama Bhat, MD
mi
from
Roseville, CA
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Office of Anupama Bhat, MD
mi
from
Roseville, CA
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Dr. Jeffrey E. Poiley, MD , Office of
mi
from
Orlando, FL
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Dr. Jeffrey E. Poiley, MD , Office of
mi
from
Orlando, FL
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Arthritis and Rheumatic Care Center
mi
from
South Miami, FL
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Arthritis and Rheumatic Care Center
mi
from
South Miami, FL
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Arthritis Treatment Center
mi
from
Frederick, MD
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Arthritis Treatment Center
mi
from
Frederick, MD
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
OMI- Organizacion Medica de Investigacion
mi
from
Buenos Aires,
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
OMI- Organizacion Medica de Investigacion
mi
from
Buenos Aires,
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Suncoast Medical Clinic
mi
from
Saint Petersburg, FL
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Suncoast Medical Clinic
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
BayCare Medical Group, Inc.
mi
from
Tampa, FL
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
BayCare Medical Group, Inc.
mi
from
Tampa, FL
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
The Center for Rheumatology and Bone Research
mi
from
Wheaton, MD
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
The Center for Rheumatology and Bone Research
mi
from
Wheaton, MD
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Office of David R. Mandel, MD, Inc.
mi
from
Mayfield, OH
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Office of David R. Mandel, MD, Inc.
mi
from
Mayfield, OH
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
The Vancouver Clinic, Inc, PS
mi
from
Vancouver, WA
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
The Vancouver Clinic, Inc, PS
mi
from
Vancouver, WA
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
NEA Baptist Clinic
mi
from
Jonesboro, AR
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
NEA Baptist Clinic
mi
from
Jonesboro, AR
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Ronald Reagan UCLA Medical Center - Drug Information Center
mi
from
Los Angeles, CA
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Ronald Reagan UCLA Medical Center - Drug Information Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Jeffrey D. Lieberman, MD, PC
mi
from
Decatur, GA
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Jeffrey D. Lieberman, MD, PC
mi
from
Decatur, GA
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
St. Luke's Clinic - Rheumatology
mi
from
Boise, ID
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
St. Luke's Clinic - Rheumatology
mi
from
Boise, ID
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
St. Luke's Intermountain Research Center
mi
from
Boise, ID
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
St. Luke's Intermountain Research Center
mi
from
Boise, ID
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Farmbrook Radiology Associates
mi
from
Southfield, MI
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Farmbrook Radiology Associates
mi
from
Southfield, MI
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Clinical Pharmacology Study Group
mi
from
Massachusetts, NE
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Clinical Pharmacology Study Group
mi
from
Massachusetts, NE
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Seattle Rheumatology Associates
mi
from
Seattle, WA
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Seattle Rheumatology Associates
mi
from
Seattle, WA
Click here to add this to my saved trials
Ankle Joint Replacement Outcomes Study
Salto Talaris Anatomic Ankle Arthroplasty Outcomes Study
Status: Enrolling
Updated:  12/31/1969
Medical College of Wisconsin
mi
from
Milwaukee, WI
Ankle Joint Replacement Outcomes Study
Salto Talaris Anatomic Ankle Arthroplasty Outcomes Study
Status: Enrolling
Updated: 12/31/1969
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Ankle Joint Replacement Outcomes Study
Salto Talaris Anatomic Ankle Arthroplasty Outcomes Study
Status: Enrolling
Updated:  12/31/1969
Foot and Ankle Center of South Texas
mi
from
San Antonio, TX
Ankle Joint Replacement Outcomes Study
Salto Talaris Anatomic Ankle Arthroplasty Outcomes Study
Status: Enrolling
Updated: 12/31/1969
Foot and Ankle Center of South Texas
mi
from
San Antonio, TX
Click here to add this to my saved trials
Duke Autoimmunity in Pregnancy Registry
Duke Autoimmunity in Pregnancy Registry
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Duke Autoimmunity in Pregnancy Registry
Duke Autoimmunity in Pregnancy Registry
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis
Pilot Study of the Safety and Efficacy of Quadrivalent Human Papillomavirus Vaccine (Gardasil®) in Female Subjects With Juvenile Idiopathic Arthritis (JIA)/ Seronegative Arthritis
Status: Enrolling
Updated:  12/31/1969
University of Chicago
mi
from
Chicago, IL
Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis
Pilot Study of the Safety and Efficacy of Quadrivalent Human Papillomavirus Vaccine (Gardasil®) in Female Subjects With Juvenile Idiopathic Arthritis (JIA)/ Seronegative Arthritis
Status: Enrolling
Updated: 12/31/1969
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis
Pilot Study of the Safety and Efficacy of Quadrivalent Human Papillomavirus Vaccine (Gardasil®) in Female Subjects With Juvenile Idiopathic Arthritis (JIA)/ Seronegative Arthritis
Status: Enrolling
Updated:  12/31/1969
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis
Pilot Study of the Safety and Efficacy of Quadrivalent Human Papillomavirus Vaccine (Gardasil®) in Female Subjects With Juvenile Idiopathic Arthritis (JIA)/ Seronegative Arthritis
Status: Enrolling
Updated: 12/31/1969
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis
Pilot Study of the Safety and Efficacy of Quadrivalent Human Papillomavirus Vaccine (Gardasil®) in Female Subjects With Juvenile Idiopathic Arthritis (JIA)/ Seronegative Arthritis
Status: Enrolling
Updated:  12/31/1969
Metrohealth
mi
from
Cleveland, OH
Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis
Pilot Study of the Safety and Efficacy of Quadrivalent Human Papillomavirus Vaccine (Gardasil®) in Female Subjects With Juvenile Idiopathic Arthritis (JIA)/ Seronegative Arthritis
Status: Enrolling
Updated: 12/31/1969
Metrohealth
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis
Pilot Study of the Safety and Efficacy of Quadrivalent Human Papillomavirus Vaccine (Gardasil®) in Female Subjects With Juvenile Idiopathic Arthritis (JIA)/ Seronegative Arthritis
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis
Pilot Study of the Safety and Efficacy of Quadrivalent Human Papillomavirus Vaccine (Gardasil®) in Female Subjects With Juvenile Idiopathic Arthritis (JIA)/ Seronegative Arthritis
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis.
A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis.
Status: Enrolling
Updated:  12/31/1969
Arthritis Research of Florida, Inc.
mi
from
Palm Harbor, FL
A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis.
A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis.
Status: Enrolling
Updated: 12/31/1969
Arthritis Research of Florida, Inc.
mi
from
Palm Harbor, FL
Click here to add this to my saved trials
A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis.
A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis.
Status: Enrolling
Updated:  12/31/1969
University of South Florida
mi
from
Tampa, FL
A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis.
A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis.
Status: Enrolling
Updated: 12/31/1969
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
Birmingham Hip Resurfacing System (BHR) Post Approval Study: A Prospective, Multi-Centered Study of the Birmingham Hip Resurfacing System
Status: Enrolling
Updated:  12/31/1969
Tucson Orthopaedic Institute
mi
from
Tucson, AZ
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
Birmingham Hip Resurfacing System (BHR) Post Approval Study: A Prospective, Multi-Centered Study of the Birmingham Hip Resurfacing System
Status: Enrolling
Updated: 12/31/1969
Tucson Orthopaedic Institute
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
Birmingham Hip Resurfacing System (BHR) Post Approval Study: A Prospective, Multi-Centered Study of the Birmingham Hip Resurfacing System
Status: Enrolling
Updated:  12/31/1969
Center for Orthopaedics
mi
from
Lake Charles, LA
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
Birmingham Hip Resurfacing System (BHR) Post Approval Study: A Prospective, Multi-Centered Study of the Birmingham Hip Resurfacing System
Status: Enrolling
Updated: 12/31/1969
Center for Orthopaedics
mi
from
Lake Charles, LA
Click here to add this to my saved trials
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
Birmingham Hip Resurfacing System (BHR) Post Approval Study: A Prospective, Multi-Centered Study of the Birmingham Hip Resurfacing System
Status: Enrolling
Updated:  12/31/1969
Hospital for Special Surgery
mi
from
New York, NY
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
Birmingham Hip Resurfacing System (BHR) Post Approval Study: A Prospective, Multi-Centered Study of the Birmingham Hip Resurfacing System
Status: Enrolling
Updated: 12/31/1969
Hospital for Special Surgery
mi
from
New York, NY
Click here to add this to my saved trials
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
Birmingham Hip Resurfacing System (BHR) Post Approval Study: A Prospective, Multi-Centered Study of the Birmingham Hip Resurfacing System
Status: Enrolling
Updated:  12/31/1969
Univ of Rochester Medical Center
mi
from
Rochester, NY
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
Birmingham Hip Resurfacing System (BHR) Post Approval Study: A Prospective, Multi-Centered Study of the Birmingham Hip Resurfacing System
Status: Enrolling
Updated: 12/31/1969
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
Birmingham Hip Resurfacing System (BHR) Post Approval Study: A Prospective, Multi-Centered Study of the Birmingham Hip Resurfacing System
Status: Enrolling
Updated:  12/31/1969
OrthoCarolina
mi
from
Charlotte, NC
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
Birmingham Hip Resurfacing System (BHR) Post Approval Study: A Prospective, Multi-Centered Study of the Birmingham Hip Resurfacing System
Status: Enrolling
Updated: 12/31/1969
OrthoCarolina
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
Birmingham Hip Resurfacing System (BHR) Post Approval Study: A Prospective, Multi-Centered Study of the Birmingham Hip Resurfacing System
Status: Enrolling
Updated:  12/31/1969
Anderson Orthopaedic Clinic
mi
from
Alexandria, VA
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
Birmingham Hip Resurfacing System (BHR) Post Approval Study: A Prospective, Multi-Centered Study of the Birmingham Hip Resurfacing System
Status: Enrolling
Updated: 12/31/1969
Anderson Orthopaedic Clinic
mi
from
Alexandria, VA
Click here to add this to my saved trials
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
Birmingham Hip Resurfacing System (BHR) Post Approval Study: A Prospective, Multi-Centered Study of the Birmingham Hip Resurfacing System
Status: Enrolling
Updated:  12/31/1969
Aurora Medical Center
mi
from
Grafton, WI
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
Birmingham Hip Resurfacing System (BHR) Post Approval Study: A Prospective, Multi-Centered Study of the Birmingham Hip Resurfacing System
Status: Enrolling
Updated: 12/31/1969
Aurora Medical Center
mi
from
Grafton, WI
Click here to add this to my saved trials
Hip Osteoarthritis: Effects of Exercise Programs on Pain and Disability
Hip Osteoarthritis: Effects of Structured Exercise Programs on Pain and Long-term Disability
Status: Enrolling
Updated:  12/31/1969
Oregon Health & Science University Center for Health & Healing
mi
from
Portland, OR
Hip Osteoarthritis: Effects of Exercise Programs on Pain and Disability
Hip Osteoarthritis: Effects of Structured Exercise Programs on Pain and Long-term Disability
Status: Enrolling
Updated: 12/31/1969
Oregon Health & Science University Center for Health & Healing
mi
from
Portland, OR
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
AZ Arthritis and Rheum Researc /ID# 21023
mi
from
Phoenix, AZ
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
AZ Arthritis and Rheum Researc /ID# 21023
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
Catalina Pointe Clinical Res /ID# 40227
mi
from
Tucson, AZ
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
Catalina Pointe Clinical Res /ID# 40227
mi
from
Tucson, AZ
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
Arkansas Children's Hospital /ID# 23505
mi
from
Little Rock, AR
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
Arkansas Children's Hospital /ID# 23505
mi
from
Little Rock, AR
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
Childrens Hospital LA /ID# 24386
mi
from
Los Angeles, CA
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
Childrens Hospital LA /ID# 24386
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
Children's Natl Med Ctr /ID# 23506
mi
from
Washington,
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
Children's Natl Med Ctr /ID# 23506
mi
from
Washington,
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
Arthritis Associates South FL /ID# 17001
mi
from
Delray Beach, FL
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
Arthritis Associates South FL /ID# 17001
mi
from
Delray Beach, FL
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
Childrens Hospital of Chicago /ID# 20966
mi
from
Chicago, IL
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
Childrens Hospital of Chicago /ID# 20966
mi
from
Chicago, IL
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
University of Chicago /ID# 21981
mi
from
Chicago, IL
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
University of Chicago /ID# 21981
mi
from
Chicago, IL
Click here to add this to my saved trials